rediff.com
e.g. Tata motors, Reliance MF, 500570
Suven Pharmaceuticals Ltd. - Research Center
543064 SUVENPHAR Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Quarterly results in brief
(Rs crore)
Mar' 24 Dec' 23 Sep' 23 Jun' 23 Mar' 23
Sales 243.52 212.83 224.62 344.03 364.39
Operating profit 72.14 68.14 97.35 169.88 174.63
Interest 2.29 1.27 0.50 1.15 2.29
Gross profit 86.72 80.84 111.05 178.79 183.09
EPS (Rs) 2.10 2.06 2.94 4.88 5.11
Quarterly  results in details
Mar' 24 Dec' 23 Sep' 23 Jun' 23 Mar' 23
Other income 16.87 13.97 14.20 10.06 10.75
Stock adjustment 17.02 6.39 8.97 21.50 20.88
Raw material 63.16 60.65 46.95 77.62 89.57
Power and fuel - - - - -
Employee expenses 37.10 30.62 26.51 26.27 22.90
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - 2.01
Expenses capitalised - - - - -
Other expenses 54.10 47.03 44.83 48.75 54.41
Provisions made - - - - -
Depreciation 15.66 11.33 10.48 11.15 10.63
Taxation 17.62 17.14 25.84 43.35 42.30
Net profit / loss 53.43 52.36 74.73 124.29 130.16
Extra ordinary item - - - - -
Prior year adjustments - - - - -
Equity capital 25.46 25.46 25.46 25.46 25.46
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 29.62 32.01 43.34 49.38 47.92
GPM (%) 33.30 35.64 46.50 50.49 48.81
NPM (%) 20.52 23.09 31.29 35.10 34.70
Close
Add Suven Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Suven Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close